Chronic Kidney Disease (CKD) Symptoms Across Different Stages

Chronic Kidney Disease (CKD), as a prolonged, progressive illness, is commonly subdivided into five different stages to better understand and frame disease progression. These stages, ranging from 1 to 5, are designed to outline the decline in kidney function, with stage 1 defined by very mild damage and stage 5 indicating kidney failure or End-Stage Renal Disease (ESRD), where the patient's kidneys have lost nearly all their ability to function effectively.

A closer look at these stages can provide us with critical insights. For instance, Stage 1 and 2 CKD reflect minimal kidney damage with relatively normal or mildly reduced kidney function. As we progress to stage 3, patients begin to experience moderate to severe reduction in kidney function. Stage 4 CKD represents a severe reduction in kidney function, and extensive measures are needed to prevent additional damage. During the final stage, Stage 5 (ESRD or kidney failure), the kidneys have lost almost all their functionality. Dialysis or a kidney transplant is often necessary for survival as the body cannot excrete waste products on its own. Monitoring these stages is crucial, as it allows healthcare providers to intervene and manage CKD more effectively.

Recognising the diverse symptoms of Chronic Kidney Disease (CKD) that fluctuate as the disease progresses through its different stages is imperative for effective management and early intervention.

In the initial stage of Chronic Kidney Disease (CKD), the symptoms are often subtle and easy to overlook. Most people with stage 1 CKD are unaware of their condition, as the kidney function can still be normal or only mildly reduced at this point. Nevertheless, certain signs may point towards potential kidney diseases. Incidents of kidney stones, for instance, might indicate a need for further investigation, prompting medical professionals to advise patients for blood tests or urine tests.

Blood tests and urine tests can be instrumental in revealing abnormalities associated with kidney diseases, even in this preliminary stage of CKD. The tests primarily focus on the levels of creatinine and urea in the blood and the presence of proteins in urine— specifically albumin. While protein leakage is still minimal in stage 1, its detection can signal the early onset of CKD. A comprehensive examination and precise diagnosis at this stage can lead to efficient and successful treatment interventions, preventing the disease from advancing to more severe stages.

In the progression of Chronic Kidney Disease (CKD), Stage 2 is often a critical juncture as it can commonly retain characteristics of Stage 1 yet simultaneously manifest more prominent signs of kidney damage. Individuals with a history of kidney problems, including conditions like polycystic kidney disease, may start to exhibit more pronounced symptoms during this phase. The severity of these symptoms can widely vary, heavily depending on the overall health, lifestyle, and the individual's responsiveness to initial treatment measures.

As the disease transitions from Stage 1 to Stage 2, markers of kidney health, like glomerular filtration rate, may begin to show signs of decline, signalling that the kidney damage is worsening. Furthermore, at this stage, signs of kidney dysfunction become more apparent in laboratory tests despite patients continuing to lead seemingly normal lives with little to no perceptible physical discomfort. It is this inconspicuous nature of Stage 2 CKD that makes it challenging for early diagnosis. By increasing awareness of the subtle symptoms and understanding the range of available treatment options, patients can better manage their kidney health and potentially slow the progression of the disease.

Chronic kidney failure becomes significantly noticeable during stage 3 of Chronic Kidney Disease (CKD). At this point, individuals start observing more severe symptoms than in previous stages. The kidneys, with their essential role in filtering the blood and maintaining balance in our bodies, are now operating at a reduced capacity. For some people, kidney failure may initially present as rapid fatigue and a decrease in appetite. Other symptoms can include frequent urination, especially at night, fluid retention causing swelling in the limbs, and, in certain instances, a person might also notice a yellowish colour in their skin.

As individuals continue to navigate through this stage, it's possible to see an exacerbation of previous symptoms or the onset of new ones linked to loss of kidney function. High blood pressure, anaemia, and early bone disease often surface. The kidneys' reduced capacity to filter out waste can lead to kidney damage, accelerated by high blood pressure. As the disease progresses towards end-stage kidney failure, the symptoms become even more severe, making it pivotal to manage stage 3 CKD correctly. It is encouraged that individuals at this stage consult with their healthcare provider regularly to monitor and manage these symptoms effectively.

Stage 4 Chronic Kidney Disease (CKD) is a severe stage where the kidneys have lost a significant portion of their function, which can drastically aggravate the symptoms experienced by the patient. Manifestations may become increasingly severe and noticeably impact a patient's quality of life. This stage is characterised by an exponential increase in fatigue, difficulty in concentrating, reduced appetite, and trouble sleeping. Some patients might even experience a change in the colour of their skin, becoming darker and appearing more 'unhealthy'.

At this advanced stage, the treatment for kidney disease is focused on managing symptoms and causes to reduce complications and slow down the further progression of the disease. Methods of treatment may include maintaining a specific diet, intake of prescribed medications, and lifestyle changes that include regular exercise and smoking cessation. However, kidney transplantation becomes more likely to be discussed as a topic in medical consultations at this phase of the disease. Preparing for potential transplantation might thus become a significant concern for patients suffering from Stage 4 CKD, adding another layer of complexity to their daily lives.

Stage 5 Chronic Kidney Disease (CKD), also known as End-stage Renal Disease (ESRD), represents the most severe phase of this condition. Symptoms during this stage often become serious and can dramatically compromise a patient's quality of life. Signs may include decreased urine output, consistent fatigue, difficulty in concentrating, loss of appetite and nausea, amongst others. This spike in symptom severity is essentially indicative of the considerable damage your kidneys are unable to self-repair.

One of the common causes of progression to this advanced stage may include long-term conditions such as diabetes or high blood pressure that, when not effectively managed, can place undue strain on your kidneys. Diagnosis at this stage of the disease necessitates immediate medical intervention, often in the form of dialysis or kidney transplantation, underlining the urgent need for a comprehensive and individually tailored treatment plan. It is crucial to understand that renal disease, particularly at this advanced stage, requires sustained medical management to mitigate further damage and maintain a patient's overall well-being.

On an individual level, understanding and recognising CKD symptoms may empower patients with kidney disease to proactively manage their condition. This is incredibly vital, especially for those with advanced kidney disease, where daily life can be significantly impacted. Persistent tiredness, difficulty sleeping, or shortness of breath could be signs of progressing disease demanding urgent medical attention. Additionally, accurate symptom tracking can facilitate better communication with healthcare professionals, leading to more personalised and effective treatment plans.

Dr Alvin Ng is a nephrologist in Singapore with more than 20 years of experience. He specialises in the diagnosis and management of a wide range of kidney conditions and is committed to providing comprehensive, personalised and evidence-based care for patients with kidney disease.

Prior to private practice, Dr Ng served as a consultant nephrologist at Changi General Hospital, where he was Director of the Peritoneal Dialysis Service and a member of the MOH Peritoneal Dialysis Workgroup. He has also held leadership roles within the Singapore Society of Nephrology and has been actively involved in the education of medical students, junior doctors and specialist trainees. His contributions to patient care, medical education and professional service have been recognised through multiple awards.